Neutral
Does Bullish Myqorzo Launch Coverage and New Shelf Registration Change The Bull Case For Cytokinetics (CYTK)?
Cytokinetics recently filed a US$76.29 million shelf registration and held its annual stockholder meeting; simultaneously, new bullish analyst coverag...